SlideShare a Scribd company logo
VESICOURETERAL REFLUX DR BHARAT SHARMA
MODERATOR- DR GAURAV
KOCHHAR
INTRODUCTION
Vesicoureteral ref lux (VUR) represents the retrograde flow of urine
from the bladder to the upper urinary tract
Galen and da Vinci:
- First references to VUR by Western medicine
- UVJ as a mediator of unidirectional flow of urine from the kidneys to
the bladder
Hutch(1952): Relationship between VUR and chronic pyelonephritis in
paraplegic patients
Hodson(1959):UTI and renal scarring carried a high likelihood of VUR
in children
DEMOGRAPHY
Incidence 0.4-1.8% in overall pediatric population
VUR in children with UTI- 30 - 50% (more in infants >
70%)
- 17% without UTI.
VUR in Antenatal Hydronephrosis – 15-38%
Highest incidence of VUR – Infants & Post Natal Renal
abnormalities
GENDER
 Male
 present at younger
age
 Severe degree of VUR
 Uncircumcised male
12X
INHERITANCE
 Autosomal Dominant
 Identical twins- 80-
100%
 Other siblings 40-50%
 Parent to child
transmission-60%
REFLUX IN FETUS
 Related to fetal/
Antenatal HDN
 HDN has low specificity
for postnatal VUR
 38% VUR in Antenatal
HDN
 19% VUR - Bilaterally
Race
Caucasian 3.4:: 1 Africans
Caucasian girls increased risk of scarring associated
with VUR
Reflux in female African tends to resolve faster and
also has lower grade at presentation
Caucasians are likely to develop Anti reflux
mechanism comparatively later in life.
AGE
SIBLING REFLUX
Prevalence of VUR in siblings to be approximately 40-50%
Prevalence - 7% in older siblings
- 100% in identical twin siblings.
Now the concern arises if screening should be done in
asymptomatic sibling????
Renal consequences of reflux that are important than
reflux itself
So Initially non invasive screening (Renal USG)
If associated UTI/ BBD in sibling then consider invasive
(Renal Scintigraphy)
Age of screening in Sibling Reflux
Not for age>5 yrs (less chances of pyelonephritis or
scarring
Sibling > 5 yrs if normal kidney with or without VUR –
less significant
Sibling< 5 yrs with cortical defects – have most to
lose by febrile UTI
GENES
Probably many genes are involved:
- PAX2
- GDNF-RET
- UPK3
- AGTR2-ACE
No specific gene product or functional role for these
loci in reflux has yet been identified
ANATOMICAL FEATURES AND
EMBRYOLOGIC ORIGINS OF THE
URETEROVESICAL JUNCTION
The UVJ is anatomically and functionally adapted to
allow intermittent passage of the urinary bolus from
the ureter into the bladder while preventing the
retrograde flow of bladder urine back toward the
kidney during storage and micturition.
Oblique intramural path (intramural ureter) and
extends through a submucosal tunnel of appropriate
length (submucosal ureter) to open onto the trigone
PASSIVE MECHANISM
“Flap valve” configuration causes the intramural and
submucosal ureter to be compressed with progressive
bladder filling against the detrusor muscle backing,
Intravesical length of ureter
Neonates -0.5 cm
Adults- 1.3 cms(2-2.5cms), by 10-12 yrs of age
Active Ureteral Trigonal
Mechanism
 BELL’S MUSCLE
 Ureteral
longitudinal muscle
extending into the
trigone forming
superficial trigone
 Crosses the other
side to mix with
contralateral
ureteral
longitudinal muscle
 In males – extends
upto proximal
veromontanum
 In females - dorsal
 MIDDLE CIRCULAR MUSCLE
 Extends upto ureteral hiatus
 WALDEYER’S SHEATH
 Adventitia of ureter just outside the bladder wall fuses with
fibromuscular sheath that encircles the ureter
 Due to waldeyers sheath anchorage, ureter can freely slide
leading to efflux of bolus
 INTERMEDIATE LAYER OF URETER
 Likely to have role in ureter trigonal relationship
 Gives contribution to Deep Trigone
 Rich innervation by nor adrenenrgic receptors
 Homologus to BELL’S muscle
EVIDENCE OF URETERAL TRIGONE RELATIONSHIP
L3-L5 U/L SYMPATHECTOMY- reflux or dilated ureter
Trigonal stimulation- by electric / epinephrine inj and
bladder distension cause decrease functional
occlusion of ureter
Trigonal and uretric continuation- if surgically
excised VUR present, But with healing VUR resolves
RELATION WITH FLAP VALVE
MECHANISM
Trigonal competency- to maintain ureteral length and obliquity
of intravesical ureter
Inadequate Trigonal function- lateral displacement of ureteric
orifice , migration away from bladder neck during filling leading
to reduction in intravesical length
Lateral displacement of ureteric orifice and its abnormal
appearences in association with VUR
 D/t abnormal ureteric bud origin along the developing
mesonephric duct
 Correlation between lateral displacement of ureteric orifice
and degree pf Renal dysplasia and hypoplasia
LYON & colleagues
Heale confirmed above findings
that increased chances of VUR/
Scarring with more laterally
placed ureters
Shape of Ureter Chance of VUR(%)
Cone/ volcano 4
Stadium 28
Horseshoe 83
Lateral pillar
defect(stephens)
Golf hole 100
PRIMARY V/S SECONDARY VUR
PRIMARY
Functional and anatomical VUJ
Dysfunction
SECONDARY
Neurogenic-
Spina bifida
Infant voiding patterns
Dysfunctional voiding
Uninhibited bladder
contractions is the most
common urodynamic
abnormality associated with
reflux in neurologically
normal children.
Constipation
Non Neurogenic-
Boys- PUV (> 50% VUR),
Resolution of Reflux Post
PUV Ablation about 6
months
Girls – Ureterocele
OTHERS- ureteral duplicaiton
•Note – Intravesical pressure > 40 cm of H2O -> 80%
chances of VUR
•In Infants and children – Abnormal LUT function with
VUR without any neurogenic or anatomic cause, VUR is
due to Lower urinary tract function
•On UDS- It is d/t imperfect coordination b/w Detrusor
contraction and sphincter relaxation
•Disappaears after 2 years of age
•This is thought to result from a lack of integration
between the bladder, the external urethral sphincter,
the brainstem, and the higher cortical centers.
•Compared with normal infants, those with VUR have
an even higher voiding pressure and abnormal bladder
function, even in the absence of UTI.
•The abnormal urodynamics seen in infants with VUR
may also imply a global maldevelopment of the
trigone and proximal urethral mechanism, which
needs to funnel open in coordination with detrusor
contraction in order to induce efficient, low-pressure
emptying.
Symptoms of paediatric voiding dysfunction—
frequency,
urgency, and
Enuresis
lie on a spectrum with detrusor instability (DI) and/or
detrusor sphincter dyssynergia (DSD), and they are
often found in patients with UTI and VUR
Note- No direct causal relationship suggesting that VUR
caused by DI, but in marginally competent VUJ, DI may
exaggerate VUR
UTI & VUR
Tanagho & Collegaues- LUT Inflammation> Mildly defective
VUJ > VUR
New VUR reported after UTI
Bacterial Endototxin – ureteral smooth muscle dilation (by
inhibiton of alpha- adrenoreceptor)
UTI- hypercontractility of bladder
Note – VCUG at the time of UTI must be avoided, bcoz of false
VUR demonstration, which will be otherwise absent when
urine is sterile
CONCLUDING REMARKS
- THE CLINICAL SIGNIFICANCE OF VUR MUST BE INTERPRETED
IN CONTEXT OF GLOBAL URINARY TRACT ABNORMALITIES
GRADING OF VUR
CLINICAL FEATURES
Features of recurrent UTI:
- Fever
- Flank pain
- Pyuria.
Palpable renal mass
Delayed growth
Weight loss
DIAGNOSIS AND EVALUATION
Confirmation of Urinary Tract Infection
These include
clinical history and presence of fever;
Age of the patient
Circumcision status
Method of urine specimen collection, storage, and delivery; and
Results of urine dipstick and microscopic analyses
Colonization – Bacteriuria– may pose threat in VUR
EVALUATING UTI
Radiologic investigation for VUR
Children younger than 5 years old,
All children with a febrile UTI, and
Any male with a UTI regardless of age or fever, unless
sexually
active.
VCUG- < 2 yrs of age
- 2nd UTI with infection based on stricter culture
criteria
USG – Non Invasive – R/O gross structural defects
Prenatal USG- augmented detection of asymp reflux in
ASSESMENT OF LOWER URINARY
TRACT
Cystographic imaging
DIRECT CYSTOGRAMS
 Voiding cystourethrogram (VCUG)
 Radionuclide cystogram (RNC)
 Gold standard approaches to reflux detection.
INDIRECT CYSTOGRAMS- eg Excretory urography
Drawback- radiation exposure
Alternates- use of Colour Doppler
-Echo enhancing contrast agents
VCUG
Provides information on :
- functional dynamics
- structural anatomy
Parameters observed:
A. Static films
- bladder contour- grade of
reflux
- configuration & blunting of
calyces
- bladder neck anatomy
- urethral patency.
- presence of diverticula
- ureteroceles
B.Dynamic films:
- active reflux
C. Delayed or postvoid films:
- Crucial in documenting clearance of contrast from the
upper tracts
- Dilated PCS + Retained contrast = PUJO
Contraindicated in active cystitis
Exceptions: In children with a h/o recurrent
pyelonephritis and repeatedly negative voiding studies in
the intercurrent periods.
Single VCUG- may miss mass VUR
Need for cyclic study- improves detection rate – 12-20%
RADIONUCLIDE CYSTOGRAM
Radiation exposure 1% of VCUG
Little anatomic detail is afforded
Ideal for:
- screening
- monitoring the natural history of Disease.
- surgical follow-up of reflux
Greater sensitivity in grades II to V reflux
Grade I reflux into distal ureter is poorly detected
UROFLOWMETRY & UDS
Full pressure-volume urodynamic studies of the
bladder are not required in all reflux patients, a
minimal survey of bladder emptying characteristics
can be obtained by uroflowmetry.
May need UDS
Lack of smoothness of the flow-velocity curve shows
incomplete relaxation of the bladder outlet that delays
the natural history of reflux resolution or even
promots reflux.
Increased PVR may be a risk factor for UTI
TOP DOWN APPROACH
CONCEPT- Only clinically relevant reflux with potential
to cause renal injury is worthy of uncovering, with
critical assumption that VUR in absence of
scintigraphic Renal abnormality is unlikely to cause
future Renal damage.
DMSA> if negative> No evaluation > if Recurrent UTI –
VCUG
Drawback- further need of prospective evidence for
validity
NICE GUIDELINES
USG
CYSTOGRAPHY-
 < 6 months,
 > 6 months if dilatation on USG
DMSA (early DMSA) not recommended
Drawback-
Poor correlation b/w appearance of kidney on USG and presence of
Renal parenchymal changes or presence and grade of VUR
Need prospective study before including in clinical use
AAP GUIDELINES
CYSTOSCOPY
Routine use is not mandated.
Role immediately prior to surgery for confirming:
- orifice position
- duplication
- proximity of diverticula to the orifice
- urethral patency
PIC TECHNIQUE
POSITION OF THE INSTILLATION OF CONTRAST AT
URETERIC ORIFICE
Detects reflux under GA
Cystoscopy – 9.5 to 14 fr
Aims to detect reflux under general anesthesia in
patients with a history of febrile UTIs but a normal
VCUG
Drawbacks – Not allow for age adjusted instillation
pressures causing Iatrogenic VUR
ASSESSMENT OF UPPER TRACTS
Renal Sonography
The mainstay of renal imaging in VUR management is
ultrasonography
Quantitative assessment of renal dimensions :
- used to monitor renal growth
- impact of any intercurrent febrile episode on renal growth
- need for further assessment of renal function by
scintigraphy or the need for correction of reflux
Modern enhancements in ultrasound technology
In reflux nephropathy using adjunts such as
Color Doppler ultrasound,
Renal resistive index measurements
RENAL SCINTIGRAPHY
DMSA:
- detection of reflux-associated
renal damage
- acute pyelonephritic changes
- follow-up of reflux
SPECT imaging
-3D reconstruction
ASSOCIATED ANOMALIES
PUJ OBSTRUCTION
URETERAL DUPLICATION
BLADDER DIVERTICULA
RENAL ANOMALIES
MEGACYSTIS- URETER SYNDROME
PUJ OBSTRUCTION
- Incidence of VUR associated with PUJO = 9% - 18%
- The incidence of PUJO in patients with reflux =
0.75% to 3.6%
- Incidence with high-grade reflux = five times more
likely than lower grades of reflux
Three radiology - UPJO with reflux.
1. the pelvis shows little or no
filling, while the ureter is
dilated by contrast, this may
indicate a point of kinking
secondary to reflux or from a
primary UPJO (Fig. 137-13).
2.Contrast that does enter the
pelvis may be poorly visualized
because of dilution in a large
pelvic volume and exhibits a
markedly reduced radiodensity
compared with the ureter or
bladder.
3.Large pelvis that fails to exhibit
Hollowell and colleagues (1989) - three clinical categories of
concomitant obstruction and reflux.
Group 1- Primary UPJO and incidental low-grade reflux,
Group 2- Secondary UPJO from high-grade reflux. These two groups
represent true anatomic obstruction for which pyeloplasty is
recommended.
Group 3 represents only significant dilation of the upper tracts,
which is confirmed by documenting good drainage images by
cystography or renal scintigraphy
.
Cause of Secondary UPJO-
1. High-grade reflux may result in kinking of the upper ureter
and adjacent pelvic junction.
2. The chronic effects of reflux also may stretch the renal
pelvis so that atonicity and an inability to propel urine
through the UPJ may occur (Whitaker, 1973).
3. In the setting of UTI propagated to the upper tracts by
reflux, inflammation and ureteritis also can contribute to
transient or chronic obstruction at the UPJ.
Nevertheless, the guiding therapeutic principle is the
preservation of renal function.
Although sterile reflux may be observed,
UPJ obstruction even in the absence of infection may jeopardize
renal function. Therefore, in the presence of reflux, if
scintigraphy with catheter drainage confirms obstruction,
pyeloplasty should be performed.
URETERAL DUPLICAITON
- VUR is the most common abnormality associated with complete
ureteral duplication.
- reflux occurs most commonly into the lower pole.
This relationship is based on the studies of Weigert and Meyer, who
documented the more lateral and proximal insertion of the lower pole
ureter associated with a shorter intramural ureter at VUJ
BLADDER DIVERTICULA
- Outpouching of mucosa between detrusor muscle bundles without
any true muscle backing itself
- Cause of reflux:
Paraureteral diverticulum- anatomic point of origin at or near the UVJ,
compromise the antireflux configuration of the UVJ to cause reflux
Large paraureteral diverticulum could expand within the Waldeyer
fascia to cause ureteral obstruction or project forward into the
bladder to obstruct the bladder outlet, much as a ureterocele, and
incite secondary reflux
Reflux associated with paraureteral diverticula resolves at rates
similar to that of primary reflux and should be managed according to
the prevailing indications for the reflux itself, irrespective of the
diverticulum
RENAL ANOMALIES
- Renal agenesis:
 Rate of contralateral renal pathology -46%
 VUR – MC contralateral defect(28%)
- MCDK: contralateral reflux 26% , majority were low grade I & II
- Presence mandates VCUG
MEGACYSTIS-MEGAURETER
SYNDROME- More common in males
- Differentiation from PUV
Massive bilateral VUR can cause a gradual remodeling of the entire
upper urinary tract
Voiding studies - demonstrate an open posterior urethra and
differentiate from
 posterior valves or
 prune-belly syndrome
Vesicostomy – temporary
OTHER ASSOCAITIONS
VACTERL association (Vertebral, Anal, Cardiac, TracheoEsophageal,
Renal, and Limb anomalies),
CHARGE syndrome (Coloboma, Heart disease, Atresia choanae,
Retarded development, Genital hypoplasia, and Ear anomalies), and
Imperforate anus.
VCUG is the initial study of choice to disclose both dysfunction at the
UVJ and overall bladder and bladder outlet anatomy
PREGNANCY AND REFLUX
Bladder tone decreases because of edema and hyperemia, changes
that predispose the patient to bacteriuria. In addition, urine volume
increases in the upper collecting system as the physiologic dilation
MANAGEMENT
NON SURGICAL
SURGICAL
NON SURGICAL MANAGEMENT
Nonsurgical therapy is based on the following principles:
(1) Higher grades of VUR - increased risk of pyelonephritis
(2) VUR often resolves over time
(3) Sterile VUR is not harmful to the kidneys, if bladder function is
normal
(4) UTI with VUR - pyelonephritis, l/t renal scarring
(5) Morbidity or complications of VUR can be decreased by preventing
UTI.
OPTIONS FOR NON SURGICAL
MANAGEMENT
1. Antibiotic prophylaxis
 a. Daily
 b. Intermittent (i.e., treatment of UTIs
when they are diagnosed)
2. Bladder training (urotherapy)
3. Treatment of BBD: Timed
voiding
 a. Treatment of constipation
 b. Anticholinergic
 c. Alpha-blocker
 d. Biofeedback
4. Periodic assessment of reflux
and child well-being
 a. Serial assessment of blood pressure,
renal function,
 and somatic growth
 b. Serial urinalysis or urine culture
REFLUX RESOLUTION
Exact mechanism not known-
Probable mechanisms are –
 Intramural ureteral lengthens
 Bladder growth and bladder function maturation
Grade Resolution rate (%)
Grade I 92
Grade II 81
Grade III 70
Grade III B/L 12.5
Grade IV 50
Grade IV B/L 10
ANTIBIOTIC PROPHYLAXIS
Controversial data from studies
2010- AUA- VUR Guidelines
Recommended Ab Prophylaxis- < 1 year of age
> 1 yr of age – optional treatment
If child with VUR develops febrile UTI- Initiate prophylaxis
Daily prophylaxis for GIRLS – III- IV VUR
BOYS- IV- V VUR
Note- Children with Grade I & II , Boys with Grade III may not benefit
form Antibiotic prophylaxis until they have Bowel Bladder
Dysfunction.
Common drugs-
 TMP-SMZ- excreted in urine
 Allergic skin reactions(MC)
 Anaphylaxis(Rare)
 Neutropenia, Thrombocytopenia
 Eosinophilia
 Photosensitivity
 Dental caries- d/t fructose in liquid preparation
 Stevens Johnson Syndrome
 Nitrofurantoin – excreted in urine,
 S/E gastric upset,
 nausea,
 poor medication taste
 Amoxicillin – babies upto 2 months (50-75 mg OD or BD)
 cephalexin
BOWEL BLADDER DYSFUNCTION
BBD is used to describe children with
Abnormal lower urinary tract symptoms of storage and/or emptying,
which include lower urinary tract conditions,
 overactive bladder and urge incontinence,
 Voiding postponement,
 underactive bladder, and
 Dysfunctional voiding,
Abnormal bowel patterns
 constipation and
 encopresis.
BBD IN INFANTS
BBD in >2-year-old children is characterized by a combination of the
following symptoms:
 urgency,
 urge incontinence,
 frequency,
 Infrequent voiding, and
 constipation.
Nearly half of infants with dilating VUR have dysfunctional voiding,
 including enlarged bladder capacity,
 overactive bladder, and
 incomplete bladder emptying;
 bowel dysfunction has not been systematically assessed in this patient population.
PHARMACOLOGIC THERAPY
ANTICHOLINERGIC THERAPY
Oxybutynin - 2.5–5 mg tid
approved for use in children
Hyoscyamine- 0.125-0.25 mg qid
sunlingual
Tolterodine- 1-2 mg bd
Tropsium 10- 25 mg bd
Dairfenacin
Solifenacin
propiverine
ALPHA BLOCKER THERAPY
For pelvic floor overactivity and
significant post void residual urine
volumes
Doxazosin 0.5 mg- decrease in
incontinence
SURGICAL MANAGEMENT
PRINCIPLES OF SURGICAL MANAGEMENT
1. Exclude secondary reflux
2. Adequate ureteral mobilization without tension and protection of the
ureteral blood supply
3. A generous submucosal tunnel should be fashioned
4. Attention should be directed to prevent angulation and twisting
bladder tissues must be handled gently
5. Attention to muscular backing of ureter to achieve effective anti refux
mechanism.
6. Creation of submucosal tunnel that satisfy 5:1 ratio of length and
width recommended by Paquin.
INDICATIONS
ABSOLUTE INDICATIONS :
Breakthrough urinary tract infections
Failure of medical management
- patient noncompliance
- persistance of reflux with prolonged medical management.
- progressive deterioration in renal function.
Ureteral obstruction assoc with VUR
Refluxing ureter opening into bladder diverticulum
Cystoscopic observation of golf hole orifice
RELATIVE INDICATIONS :
Presence of massive reflux – gr IV & V
Reflux associated with paraureteral diverticulum
In girls whose reflux persists after they have reached the full
somatic growth potential at puberty.
Parental preference
CLASSIFICATION
According to approach :
Intravesical
Extravesical
Combined
According to the position of the sub mucosal
tunnel in relation to the original hiatus :
Suprahiatal
Infrahiatal
FOLLOW UP
Discharged on uro-prophylaxis
Monitoring of pt’s
- BP
- renal function
- urine analysis
Follow up USG and urine c/s after 6-12 weeks.
VCUG after 3 mnths
Discontinuation of uroprophylaxis on resolution of
reflux
DMSA after 1 yr (not mandatory)
COMPLICATIONS
Persistent Reflux.
Early reflux following ureteroneocystostomy is usually not a
significant clinical problem and commonly resolves by 1 year on
repeat cystography.
Contralateral reflux
Seen in 5-11% cases
There was no difference noted among the various surgical
techniques, but there was a significant trend toward
development of contralateral reflux with the higher grades of
ipsilateral corrected reflux and correction of reflux in duplex
systems.
Prophylactic bilateral reimplantation for unilateral reflux, to
avoid Contralateral reflux, is not warranted on the basis of the
high spontaneous resolution rates.
Obstruction
Due to odema , clot ,twisting or kinking of ureter.
Diagnosis made by USG showing severe HDUN.
PCN or stenting has to be done.
Redo surgery may be required
ENDOSCOPIC MANAGEMENT
Injection of a bio- compatible
bulking agent beneath
intravesical portion of ureter in
sub-mucosal tunnel
Elevates the intra-vesical
ureter
narrowing of lumen
Prevents regurgitation of
urine & allows antegrade flow
ADVANTAGES
OPD based treatment
less morbidity, no mortality
No surgical scar
Success rate almost equivalent to open surgery forprimary
reflux.
DISADVANTAGES
Cost
Lower success rate compared to surgery for high grade
reflux,upto 90%.
ADVANTAGES
OPD based treatment
less morbidity, no mortality
No surgical scar
Success rate almost equivalent to open surgery for primary
reflux.
DISADVANTAGES
Cost
Lower success rate compared to surgery for high grade
reflux,upto 90%.
DEFLUX
Dextranomer/Hyaluronic Copolymer (DX/HA) is formed of crosslinked
dextranomer microspheres (80 to 250 μm in diameter) suspended in
a carrier gel of stabilized sodium hyaluronate.
DX/HA is biodegradable, the carrier gel is reabsorbed, and the
dextranomer microspheres capsulated by fibroblast migration and
collagen ingrowth.
DX/HA loses about 23% of its volume beyond 3 months of follow-
up
The appeal of Deflux is that it is a natural product that is easily
administered without a ratcheted syringe through a smaller-gauge
needle.
It is currently the preferred agent for endoscopic correction in most
TEFLON PASTE
Teflon paste is relatively inexpensive; it is viscous and requires
a ratcheted syringe for injection.
Less used now because of concerns regarding distant
migration of the PTFE particles.
Particle size 10-100μm.
Malizia demonstrated in experimental studies that the
particles can migrate to regional lymph nodes and to
distantorgans including the lung and the brain
THANK YOU

More Related Content

What's hot

Megaureter
MegaureterMegaureter
Megaureter
Faheem Andrabi
 
Pediatric urology : Vesicoureteric reflux(vur)- overview
Pediatric urology : Vesicoureteric reflux(vur)- overviewPediatric urology : Vesicoureteric reflux(vur)- overview
Pediatric urology : Vesicoureteric reflux(vur)- overview
GovtRoyapettahHospit
 
Ectopic ureter and ureterocele - Embryology and Presentation
Ectopic ureter and ureterocele - Embryology and PresentationEctopic ureter and ureterocele - Embryology and Presentation
Ectopic ureter and ureterocele - Embryology and Presentation
AbhishekPandey1012
 
Posterior urethral valves
Posterior urethral valvesPosterior urethral valves
Posterior urethral valves
Drhammad Rehman
 
VUR in Children-Overview
VUR in Children-OverviewVUR in Children-Overview
VUR in Children-Overview
vidkiddosurg
 
Vesicoureteric reflux
Vesicoureteric refluxVesicoureteric reflux
Vesicoureteric reflux
Pradeep Deb
 
Posterior urethral valve
Posterior urethral valvePosterior urethral valve
Posterior urethral valve
Dr Santosh Kumaraswamy
 
Congenital anomalies of kidney.
Congenital anomalies of kidney.Congenital anomalies of kidney.
Congenital anomalies of kidney.
GovtRoyapettahHospit
 
Antenatal hydronephrosis
Antenatal hydronephrosisAntenatal hydronephrosis
Antenatal hydronephrosis
Priyatham Kasaraneni
 
Vesico ureteric reflux
Vesico ureteric refluxVesico ureteric reflux
Vesico ureteric reflux
akifab93
 
Urodynamic studies
Urodynamic studiesUrodynamic studies
Urodynamic studies
GAURAV NAHAR
 
Obstructive Uropathy "online"
Obstructive Uropathy "online"Obstructive Uropathy "online"
Obstructive Uropathy "online"
Ayman Rashed, MD
 
LAP PYELOPLASTY
LAP PYELOPLASTYLAP PYELOPLASTY
LAP PYELOPLASTY
parikumawat
 
Ureterocele,
Ureterocele,Ureterocele,
Ureterocele,
Faheem Andrabi
 
Congenital renal anomalies
Congenital renal anomaliesCongenital renal anomalies
Congenital renal anomalies
Dev Lakhera
 
Hematuria - evaluation and management
Hematuria - evaluation and managementHematuria - evaluation and management
Hematuria - evaluation and management
GovtRoyapettahHospit
 
Posterior Urethral Valves
Posterior Urethral ValvesPosterior Urethral Valves
Posterior Urethral Valves
Efosa Aimien
 
Development and congenital anomalies of urogenital system
Development and congenital anomalies of urogenital systemDevelopment and congenital anomalies of urogenital system
Development and congenital anomalies of urogenital system
Jayeta Choudhury
 
Congenital Anomalies of the Kidney & Urinary Tract
Congenital Anomalies of the Kidney & Urinary TractCongenital Anomalies of the Kidney & Urinary Tract
Congenital Anomalies of the Kidney & Urinary Tract
Abhineet Dey
 
Vesicoureteric Reflux- commonest cause for pediatric UTI
Vesicoureteric Reflux- commonest cause for pediatric UTIVesicoureteric Reflux- commonest cause for pediatric UTI
Vesicoureteric Reflux- commonest cause for pediatric UTI
Selvaraj Balasubramani
 

What's hot (20)

Megaureter
MegaureterMegaureter
Megaureter
 
Pediatric urology : Vesicoureteric reflux(vur)- overview
Pediatric urology : Vesicoureteric reflux(vur)- overviewPediatric urology : Vesicoureteric reflux(vur)- overview
Pediatric urology : Vesicoureteric reflux(vur)- overview
 
Ectopic ureter and ureterocele - Embryology and Presentation
Ectopic ureter and ureterocele - Embryology and PresentationEctopic ureter and ureterocele - Embryology and Presentation
Ectopic ureter and ureterocele - Embryology and Presentation
 
Posterior urethral valves
Posterior urethral valvesPosterior urethral valves
Posterior urethral valves
 
VUR in Children-Overview
VUR in Children-OverviewVUR in Children-Overview
VUR in Children-Overview
 
Vesicoureteric reflux
Vesicoureteric refluxVesicoureteric reflux
Vesicoureteric reflux
 
Posterior urethral valve
Posterior urethral valvePosterior urethral valve
Posterior urethral valve
 
Congenital anomalies of kidney.
Congenital anomalies of kidney.Congenital anomalies of kidney.
Congenital anomalies of kidney.
 
Antenatal hydronephrosis
Antenatal hydronephrosisAntenatal hydronephrosis
Antenatal hydronephrosis
 
Vesico ureteric reflux
Vesico ureteric refluxVesico ureteric reflux
Vesico ureteric reflux
 
Urodynamic studies
Urodynamic studiesUrodynamic studies
Urodynamic studies
 
Obstructive Uropathy "online"
Obstructive Uropathy "online"Obstructive Uropathy "online"
Obstructive Uropathy "online"
 
LAP PYELOPLASTY
LAP PYELOPLASTYLAP PYELOPLASTY
LAP PYELOPLASTY
 
Ureterocele,
Ureterocele,Ureterocele,
Ureterocele,
 
Congenital renal anomalies
Congenital renal anomaliesCongenital renal anomalies
Congenital renal anomalies
 
Hematuria - evaluation and management
Hematuria - evaluation and managementHematuria - evaluation and management
Hematuria - evaluation and management
 
Posterior Urethral Valves
Posterior Urethral ValvesPosterior Urethral Valves
Posterior Urethral Valves
 
Development and congenital anomalies of urogenital system
Development and congenital anomalies of urogenital systemDevelopment and congenital anomalies of urogenital system
Development and congenital anomalies of urogenital system
 
Congenital Anomalies of the Kidney & Urinary Tract
Congenital Anomalies of the Kidney & Urinary TractCongenital Anomalies of the Kidney & Urinary Tract
Congenital Anomalies of the Kidney & Urinary Tract
 
Vesicoureteric Reflux- commonest cause for pediatric UTI
Vesicoureteric Reflux- commonest cause for pediatric UTIVesicoureteric Reflux- commonest cause for pediatric UTI
Vesicoureteric Reflux- commonest cause for pediatric UTI
 

Similar to Vesicoureteral reflux

PUJ obstruction.pptx
PUJ obstruction.pptxPUJ obstruction.pptx
PUJ obstruction.pptx
Hasan MH Matloob
 
Upj obstruction
Upj obstructionUpj obstruction
Upj obstruction
Eman Salman
 
Mcu rgu ppt
Mcu rgu pptMcu rgu ppt
Mcu rgu ppt
Naba Kumar Barman
 
Puj obstruction
Puj obstructionPuj obstruction
Puj obstruction
DRTALALBALLOUT
 
PEDI GU REVIEW lower tract i
PEDI GU REVIEW lower tract iPEDI GU REVIEW lower tract i
PEDI GU REVIEW lower tract i
George Chiang
 
Intravenous urography
Intravenous urographyIntravenous urography
Intravenous urography
RamanGhimire3
 
Antenatal Hydronephrosis, Hydronephrosis in Child Treatment, Delhi - Dr. Pras...
Antenatal Hydronephrosis, Hydronephrosis in Child Treatment, Delhi - Dr. Pras...Antenatal Hydronephrosis, Hydronephrosis in Child Treatment, Delhi - Dr. Pras...
Antenatal Hydronephrosis, Hydronephrosis in Child Treatment, Delhi - Dr. Pras...
Dr. Prashant Jain
 
ppv.pptx
ppv.pptxppv.pptx
ppv.pptx
revanthk99
 
POSTERIOR URETERAL VALVES (PUV )
POSTERIOR URETERAL VALVES (PUV )POSTERIOR URETERAL VALVES (PUV )
POSTERIOR URETERAL VALVES (PUV )
leelakrishnakarri
 
Pyelonephritis pediatric practice 2.ppt
Pyelonephritis  pediatric practice 2.pptPyelonephritis  pediatric practice 2.ppt
Pyelonephritis pediatric practice 2.ppt
yulia250325
 
Posterior urethral valve
Posterior urethral valvePosterior urethral valve
Posterior urethral valve
Makafui Yigah
 
Postnatal mangement of anh (2)
Postnatal mangement of anh (2)Postnatal mangement of anh (2)
Postnatal mangement of anh (2)
Mohamed Mustafa
 
Puv
PuvPuv
Megaureter ppt. Types, pathophysiology, evaluation and management.
Megaureter ppt. Types, pathophysiology, evaluation and management.Megaureter ppt. Types, pathophysiology, evaluation and management.
Megaureter ppt. Types, pathophysiology, evaluation and management.
Hussain Shah
 
Transplant in abnormal bladder
Transplant in abnormal bladderTransplant in abnormal bladder
Transplant in abnormal bladder
GAURAV NAHAR
 
Nuclear nephrology
Nuclear nephrologyNuclear nephrology
Nuclear nephrology
Ramin Sadeghi
 
Vesicoureteric reflux by dr emmanuel, godwin
Vesicoureteric reflux by dr emmanuel, godwinVesicoureteric reflux by dr emmanuel, godwin
Vesicoureteric reflux by dr emmanuel, godwin
Dr.Emmanuel Godwin
 
antenatal Hydronephrosis and approach
antenatal Hydronephrosis and approachantenatal Hydronephrosis and approach
antenatal Hydronephrosis and approach
Dr Praman Kushwah
 
Mcu
McuMcu
MCU- Micturating cysto-urethrogram
MCU- Micturating cysto-urethrogramMCU- Micturating cysto-urethrogram
MCU- Micturating cysto-urethrogram
Dr. Mohit Goel
 

Similar to Vesicoureteral reflux (20)

PUJ obstruction.pptx
PUJ obstruction.pptxPUJ obstruction.pptx
PUJ obstruction.pptx
 
Upj obstruction
Upj obstructionUpj obstruction
Upj obstruction
 
Mcu rgu ppt
Mcu rgu pptMcu rgu ppt
Mcu rgu ppt
 
Puj obstruction
Puj obstructionPuj obstruction
Puj obstruction
 
PEDI GU REVIEW lower tract i
PEDI GU REVIEW lower tract iPEDI GU REVIEW lower tract i
PEDI GU REVIEW lower tract i
 
Intravenous urography
Intravenous urographyIntravenous urography
Intravenous urography
 
Antenatal Hydronephrosis, Hydronephrosis in Child Treatment, Delhi - Dr. Pras...
Antenatal Hydronephrosis, Hydronephrosis in Child Treatment, Delhi - Dr. Pras...Antenatal Hydronephrosis, Hydronephrosis in Child Treatment, Delhi - Dr. Pras...
Antenatal Hydronephrosis, Hydronephrosis in Child Treatment, Delhi - Dr. Pras...
 
ppv.pptx
ppv.pptxppv.pptx
ppv.pptx
 
POSTERIOR URETERAL VALVES (PUV )
POSTERIOR URETERAL VALVES (PUV )POSTERIOR URETERAL VALVES (PUV )
POSTERIOR URETERAL VALVES (PUV )
 
Pyelonephritis pediatric practice 2.ppt
Pyelonephritis  pediatric practice 2.pptPyelonephritis  pediatric practice 2.ppt
Pyelonephritis pediatric practice 2.ppt
 
Posterior urethral valve
Posterior urethral valvePosterior urethral valve
Posterior urethral valve
 
Postnatal mangement of anh (2)
Postnatal mangement of anh (2)Postnatal mangement of anh (2)
Postnatal mangement of anh (2)
 
Puv
PuvPuv
Puv
 
Megaureter ppt. Types, pathophysiology, evaluation and management.
Megaureter ppt. Types, pathophysiology, evaluation and management.Megaureter ppt. Types, pathophysiology, evaluation and management.
Megaureter ppt. Types, pathophysiology, evaluation and management.
 
Transplant in abnormal bladder
Transplant in abnormal bladderTransplant in abnormal bladder
Transplant in abnormal bladder
 
Nuclear nephrology
Nuclear nephrologyNuclear nephrology
Nuclear nephrology
 
Vesicoureteric reflux by dr emmanuel, godwin
Vesicoureteric reflux by dr emmanuel, godwinVesicoureteric reflux by dr emmanuel, godwin
Vesicoureteric reflux by dr emmanuel, godwin
 
antenatal Hydronephrosis and approach
antenatal Hydronephrosis and approachantenatal Hydronephrosis and approach
antenatal Hydronephrosis and approach
 
Mcu
McuMcu
Mcu
 
MCU- Micturating cysto-urethrogram
MCU- Micturating cysto-urethrogramMCU- Micturating cysto-urethrogram
MCU- Micturating cysto-urethrogram
 

Recently uploaded

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Kunj Vihari
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
KerlynIgnacio
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
Chulalongkorn Allergy and Clinical Immunology Research Group
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
Gokuldas Hospital
 
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfTest bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
rightmanforbloodline
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
What are the different types of Dental implants.
What are the different types of Dental implants.What are the different types of Dental implants.
What are the different types of Dental implants.
Gokuldas Hospital
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 

Recently uploaded (20)

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
 
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfTest bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
What are the different types of Dental implants.
What are the different types of Dental implants.What are the different types of Dental implants.
What are the different types of Dental implants.
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 

Vesicoureteral reflux

  • 1. VESICOURETERAL REFLUX DR BHARAT SHARMA MODERATOR- DR GAURAV KOCHHAR
  • 2. INTRODUCTION Vesicoureteral ref lux (VUR) represents the retrograde flow of urine from the bladder to the upper urinary tract Galen and da Vinci: - First references to VUR by Western medicine - UVJ as a mediator of unidirectional flow of urine from the kidneys to the bladder Hutch(1952): Relationship between VUR and chronic pyelonephritis in paraplegic patients Hodson(1959):UTI and renal scarring carried a high likelihood of VUR in children
  • 3. DEMOGRAPHY Incidence 0.4-1.8% in overall pediatric population VUR in children with UTI- 30 - 50% (more in infants > 70%) - 17% without UTI. VUR in Antenatal Hydronephrosis – 15-38% Highest incidence of VUR – Infants & Post Natal Renal abnormalities
  • 4. GENDER  Male  present at younger age  Severe degree of VUR  Uncircumcised male 12X INHERITANCE  Autosomal Dominant  Identical twins- 80- 100%  Other siblings 40-50%  Parent to child transmission-60% REFLUX IN FETUS  Related to fetal/ Antenatal HDN  HDN has low specificity for postnatal VUR  38% VUR in Antenatal HDN  19% VUR - Bilaterally
  • 5. Race Caucasian 3.4:: 1 Africans Caucasian girls increased risk of scarring associated with VUR Reflux in female African tends to resolve faster and also has lower grade at presentation Caucasians are likely to develop Anti reflux mechanism comparatively later in life. AGE
  • 6. SIBLING REFLUX Prevalence of VUR in siblings to be approximately 40-50% Prevalence - 7% in older siblings - 100% in identical twin siblings. Now the concern arises if screening should be done in asymptomatic sibling???? Renal consequences of reflux that are important than reflux itself So Initially non invasive screening (Renal USG) If associated UTI/ BBD in sibling then consider invasive (Renal Scintigraphy)
  • 7. Age of screening in Sibling Reflux Not for age>5 yrs (less chances of pyelonephritis or scarring Sibling > 5 yrs if normal kidney with or without VUR – less significant Sibling< 5 yrs with cortical defects – have most to lose by febrile UTI
  • 8. GENES Probably many genes are involved: - PAX2 - GDNF-RET - UPK3 - AGTR2-ACE No specific gene product or functional role for these loci in reflux has yet been identified
  • 9. ANATOMICAL FEATURES AND EMBRYOLOGIC ORIGINS OF THE URETEROVESICAL JUNCTION The UVJ is anatomically and functionally adapted to allow intermittent passage of the urinary bolus from the ureter into the bladder while preventing the retrograde flow of bladder urine back toward the kidney during storage and micturition. Oblique intramural path (intramural ureter) and extends through a submucosal tunnel of appropriate length (submucosal ureter) to open onto the trigone
  • 10.
  • 11. PASSIVE MECHANISM “Flap valve” configuration causes the intramural and submucosal ureter to be compressed with progressive bladder filling against the detrusor muscle backing, Intravesical length of ureter Neonates -0.5 cm Adults- 1.3 cms(2-2.5cms), by 10-12 yrs of age
  • 12. Active Ureteral Trigonal Mechanism  BELL’S MUSCLE  Ureteral longitudinal muscle extending into the trigone forming superficial trigone  Crosses the other side to mix with contralateral ureteral longitudinal muscle  In males – extends upto proximal veromontanum  In females - dorsal
  • 13.  MIDDLE CIRCULAR MUSCLE  Extends upto ureteral hiatus  WALDEYER’S SHEATH  Adventitia of ureter just outside the bladder wall fuses with fibromuscular sheath that encircles the ureter  Due to waldeyers sheath anchorage, ureter can freely slide leading to efflux of bolus  INTERMEDIATE LAYER OF URETER  Likely to have role in ureter trigonal relationship  Gives contribution to Deep Trigone  Rich innervation by nor adrenenrgic receptors  Homologus to BELL’S muscle
  • 14. EVIDENCE OF URETERAL TRIGONE RELATIONSHIP L3-L5 U/L SYMPATHECTOMY- reflux or dilated ureter Trigonal stimulation- by electric / epinephrine inj and bladder distension cause decrease functional occlusion of ureter Trigonal and uretric continuation- if surgically excised VUR present, But with healing VUR resolves
  • 15. RELATION WITH FLAP VALVE MECHANISM Trigonal competency- to maintain ureteral length and obliquity of intravesical ureter Inadequate Trigonal function- lateral displacement of ureteric orifice , migration away from bladder neck during filling leading to reduction in intravesical length Lateral displacement of ureteric orifice and its abnormal appearences in association with VUR  D/t abnormal ureteric bud origin along the developing mesonephric duct  Correlation between lateral displacement of ureteric orifice and degree pf Renal dysplasia and hypoplasia
  • 16.
  • 17. LYON & colleagues Heale confirmed above findings that increased chances of VUR/ Scarring with more laterally placed ureters Shape of Ureter Chance of VUR(%) Cone/ volcano 4 Stadium 28 Horseshoe 83 Lateral pillar defect(stephens) Golf hole 100
  • 18. PRIMARY V/S SECONDARY VUR PRIMARY Functional and anatomical VUJ Dysfunction SECONDARY Neurogenic- Spina bifida Infant voiding patterns Dysfunctional voiding Uninhibited bladder contractions is the most common urodynamic abnormality associated with reflux in neurologically normal children. Constipation Non Neurogenic- Boys- PUV (> 50% VUR), Resolution of Reflux Post PUV Ablation about 6 months Girls – Ureterocele OTHERS- ureteral duplicaiton
  • 19. •Note – Intravesical pressure > 40 cm of H2O -> 80% chances of VUR •In Infants and children – Abnormal LUT function with VUR without any neurogenic or anatomic cause, VUR is due to Lower urinary tract function •On UDS- It is d/t imperfect coordination b/w Detrusor contraction and sphincter relaxation •Disappaears after 2 years of age
  • 20. •This is thought to result from a lack of integration between the bladder, the external urethral sphincter, the brainstem, and the higher cortical centers. •Compared with normal infants, those with VUR have an even higher voiding pressure and abnormal bladder function, even in the absence of UTI. •The abnormal urodynamics seen in infants with VUR may also imply a global maldevelopment of the trigone and proximal urethral mechanism, which needs to funnel open in coordination with detrusor contraction in order to induce efficient, low-pressure emptying.
  • 21. Symptoms of paediatric voiding dysfunction— frequency, urgency, and Enuresis lie on a spectrum with detrusor instability (DI) and/or detrusor sphincter dyssynergia (DSD), and they are often found in patients with UTI and VUR Note- No direct causal relationship suggesting that VUR caused by DI, but in marginally competent VUJ, DI may exaggerate VUR
  • 22. UTI & VUR Tanagho & Collegaues- LUT Inflammation> Mildly defective VUJ > VUR New VUR reported after UTI Bacterial Endototxin – ureteral smooth muscle dilation (by inhibiton of alpha- adrenoreceptor) UTI- hypercontractility of bladder Note – VCUG at the time of UTI must be avoided, bcoz of false VUR demonstration, which will be otherwise absent when urine is sterile CONCLUDING REMARKS - THE CLINICAL SIGNIFICANCE OF VUR MUST BE INTERPRETED IN CONTEXT OF GLOBAL URINARY TRACT ABNORMALITIES
  • 24. CLINICAL FEATURES Features of recurrent UTI: - Fever - Flank pain - Pyuria. Palpable renal mass Delayed growth Weight loss
  • 25. DIAGNOSIS AND EVALUATION Confirmation of Urinary Tract Infection These include clinical history and presence of fever; Age of the patient Circumcision status Method of urine specimen collection, storage, and delivery; and Results of urine dipstick and microscopic analyses Colonization – Bacteriuria– may pose threat in VUR
  • 26. EVALUATING UTI Radiologic investigation for VUR Children younger than 5 years old, All children with a febrile UTI, and Any male with a UTI regardless of age or fever, unless sexually active. VCUG- < 2 yrs of age - 2nd UTI with infection based on stricter culture criteria USG – Non Invasive – R/O gross structural defects Prenatal USG- augmented detection of asymp reflux in
  • 27. ASSESMENT OF LOWER URINARY TRACT Cystographic imaging DIRECT CYSTOGRAMS  Voiding cystourethrogram (VCUG)  Radionuclide cystogram (RNC)  Gold standard approaches to reflux detection. INDIRECT CYSTOGRAMS- eg Excretory urography Drawback- radiation exposure Alternates- use of Colour Doppler -Echo enhancing contrast agents
  • 28. VCUG Provides information on : - functional dynamics - structural anatomy Parameters observed: A. Static films - bladder contour- grade of reflux - configuration & blunting of calyces - bladder neck anatomy - urethral patency. - presence of diverticula - ureteroceles
  • 29. B.Dynamic films: - active reflux C. Delayed or postvoid films: - Crucial in documenting clearance of contrast from the upper tracts - Dilated PCS + Retained contrast = PUJO Contraindicated in active cystitis Exceptions: In children with a h/o recurrent pyelonephritis and repeatedly negative voiding studies in the intercurrent periods.
  • 30. Single VCUG- may miss mass VUR Need for cyclic study- improves detection rate – 12-20%
  • 31. RADIONUCLIDE CYSTOGRAM Radiation exposure 1% of VCUG Little anatomic detail is afforded Ideal for: - screening - monitoring the natural history of Disease. - surgical follow-up of reflux Greater sensitivity in grades II to V reflux Grade I reflux into distal ureter is poorly detected
  • 32. UROFLOWMETRY & UDS Full pressure-volume urodynamic studies of the bladder are not required in all reflux patients, a minimal survey of bladder emptying characteristics can be obtained by uroflowmetry. May need UDS Lack of smoothness of the flow-velocity curve shows incomplete relaxation of the bladder outlet that delays the natural history of reflux resolution or even promots reflux. Increased PVR may be a risk factor for UTI
  • 33. TOP DOWN APPROACH CONCEPT- Only clinically relevant reflux with potential to cause renal injury is worthy of uncovering, with critical assumption that VUR in absence of scintigraphic Renal abnormality is unlikely to cause future Renal damage. DMSA> if negative> No evaluation > if Recurrent UTI – VCUG Drawback- further need of prospective evidence for validity
  • 34. NICE GUIDELINES USG CYSTOGRAPHY-  < 6 months,  > 6 months if dilatation on USG DMSA (early DMSA) not recommended Drawback- Poor correlation b/w appearance of kidney on USG and presence of Renal parenchymal changes or presence and grade of VUR Need prospective study before including in clinical use
  • 36. CYSTOSCOPY Routine use is not mandated. Role immediately prior to surgery for confirming: - orifice position - duplication - proximity of diverticula to the orifice - urethral patency
  • 37. PIC TECHNIQUE POSITION OF THE INSTILLATION OF CONTRAST AT URETERIC ORIFICE Detects reflux under GA Cystoscopy – 9.5 to 14 fr Aims to detect reflux under general anesthesia in patients with a history of febrile UTIs but a normal VCUG Drawbacks – Not allow for age adjusted instillation pressures causing Iatrogenic VUR
  • 38. ASSESSMENT OF UPPER TRACTS Renal Sonography The mainstay of renal imaging in VUR management is ultrasonography Quantitative assessment of renal dimensions : - used to monitor renal growth - impact of any intercurrent febrile episode on renal growth - need for further assessment of renal function by scintigraphy or the need for correction of reflux
  • 39. Modern enhancements in ultrasound technology In reflux nephropathy using adjunts such as Color Doppler ultrasound, Renal resistive index measurements
  • 40. RENAL SCINTIGRAPHY DMSA: - detection of reflux-associated renal damage - acute pyelonephritic changes - follow-up of reflux SPECT imaging -3D reconstruction
  • 41. ASSOCIATED ANOMALIES PUJ OBSTRUCTION URETERAL DUPLICATION BLADDER DIVERTICULA RENAL ANOMALIES MEGACYSTIS- URETER SYNDROME
  • 42. PUJ OBSTRUCTION - Incidence of VUR associated with PUJO = 9% - 18% - The incidence of PUJO in patients with reflux = 0.75% to 3.6% - Incidence with high-grade reflux = five times more likely than lower grades of reflux
  • 43. Three radiology - UPJO with reflux. 1. the pelvis shows little or no filling, while the ureter is dilated by contrast, this may indicate a point of kinking secondary to reflux or from a primary UPJO (Fig. 137-13). 2.Contrast that does enter the pelvis may be poorly visualized because of dilution in a large pelvic volume and exhibits a markedly reduced radiodensity compared with the ureter or bladder. 3.Large pelvis that fails to exhibit
  • 44. Hollowell and colleagues (1989) - three clinical categories of concomitant obstruction and reflux. Group 1- Primary UPJO and incidental low-grade reflux, Group 2- Secondary UPJO from high-grade reflux. These two groups represent true anatomic obstruction for which pyeloplasty is recommended. Group 3 represents only significant dilation of the upper tracts, which is confirmed by documenting good drainage images by cystography or renal scintigraphy .
  • 45. Cause of Secondary UPJO- 1. High-grade reflux may result in kinking of the upper ureter and adjacent pelvic junction. 2. The chronic effects of reflux also may stretch the renal pelvis so that atonicity and an inability to propel urine through the UPJ may occur (Whitaker, 1973). 3. In the setting of UTI propagated to the upper tracts by reflux, inflammation and ureteritis also can contribute to transient or chronic obstruction at the UPJ.
  • 46. Nevertheless, the guiding therapeutic principle is the preservation of renal function. Although sterile reflux may be observed, UPJ obstruction even in the absence of infection may jeopardize renal function. Therefore, in the presence of reflux, if scintigraphy with catheter drainage confirms obstruction, pyeloplasty should be performed.
  • 47. URETERAL DUPLICAITON - VUR is the most common abnormality associated with complete ureteral duplication. - reflux occurs most commonly into the lower pole. This relationship is based on the studies of Weigert and Meyer, who documented the more lateral and proximal insertion of the lower pole ureter associated with a shorter intramural ureter at VUJ
  • 48. BLADDER DIVERTICULA - Outpouching of mucosa between detrusor muscle bundles without any true muscle backing itself - Cause of reflux: Paraureteral diverticulum- anatomic point of origin at or near the UVJ, compromise the antireflux configuration of the UVJ to cause reflux Large paraureteral diverticulum could expand within the Waldeyer fascia to cause ureteral obstruction or project forward into the bladder to obstruct the bladder outlet, much as a ureterocele, and incite secondary reflux Reflux associated with paraureteral diverticula resolves at rates similar to that of primary reflux and should be managed according to the prevailing indications for the reflux itself, irrespective of the diverticulum
  • 49. RENAL ANOMALIES - Renal agenesis:  Rate of contralateral renal pathology -46%  VUR – MC contralateral defect(28%) - MCDK: contralateral reflux 26% , majority were low grade I & II - Presence mandates VCUG
  • 50. MEGACYSTIS-MEGAURETER SYNDROME- More common in males - Differentiation from PUV Massive bilateral VUR can cause a gradual remodeling of the entire upper urinary tract Voiding studies - demonstrate an open posterior urethra and differentiate from  posterior valves or  prune-belly syndrome Vesicostomy – temporary
  • 51. OTHER ASSOCAITIONS VACTERL association (Vertebral, Anal, Cardiac, TracheoEsophageal, Renal, and Limb anomalies), CHARGE syndrome (Coloboma, Heart disease, Atresia choanae, Retarded development, Genital hypoplasia, and Ear anomalies), and Imperforate anus. VCUG is the initial study of choice to disclose both dysfunction at the UVJ and overall bladder and bladder outlet anatomy PREGNANCY AND REFLUX Bladder tone decreases because of edema and hyperemia, changes that predispose the patient to bacteriuria. In addition, urine volume increases in the upper collecting system as the physiologic dilation
  • 53. NON SURGICAL MANAGEMENT Nonsurgical therapy is based on the following principles: (1) Higher grades of VUR - increased risk of pyelonephritis (2) VUR often resolves over time (3) Sterile VUR is not harmful to the kidneys, if bladder function is normal (4) UTI with VUR - pyelonephritis, l/t renal scarring (5) Morbidity or complications of VUR can be decreased by preventing UTI.
  • 54. OPTIONS FOR NON SURGICAL MANAGEMENT 1. Antibiotic prophylaxis  a. Daily  b. Intermittent (i.e., treatment of UTIs when they are diagnosed) 2. Bladder training (urotherapy) 3. Treatment of BBD: Timed voiding  a. Treatment of constipation  b. Anticholinergic  c. Alpha-blocker  d. Biofeedback 4. Periodic assessment of reflux and child well-being  a. Serial assessment of blood pressure, renal function,  and somatic growth  b. Serial urinalysis or urine culture
  • 55. REFLUX RESOLUTION Exact mechanism not known- Probable mechanisms are –  Intramural ureteral lengthens  Bladder growth and bladder function maturation Grade Resolution rate (%) Grade I 92 Grade II 81 Grade III 70 Grade III B/L 12.5 Grade IV 50 Grade IV B/L 10
  • 56. ANTIBIOTIC PROPHYLAXIS Controversial data from studies 2010- AUA- VUR Guidelines Recommended Ab Prophylaxis- < 1 year of age > 1 yr of age – optional treatment If child with VUR develops febrile UTI- Initiate prophylaxis Daily prophylaxis for GIRLS – III- IV VUR BOYS- IV- V VUR Note- Children with Grade I & II , Boys with Grade III may not benefit form Antibiotic prophylaxis until they have Bowel Bladder Dysfunction.
  • 57. Common drugs-  TMP-SMZ- excreted in urine  Allergic skin reactions(MC)  Anaphylaxis(Rare)  Neutropenia, Thrombocytopenia  Eosinophilia  Photosensitivity  Dental caries- d/t fructose in liquid preparation  Stevens Johnson Syndrome  Nitrofurantoin – excreted in urine,  S/E gastric upset,  nausea,  poor medication taste  Amoxicillin – babies upto 2 months (50-75 mg OD or BD)  cephalexin
  • 58. BOWEL BLADDER DYSFUNCTION BBD is used to describe children with Abnormal lower urinary tract symptoms of storage and/or emptying, which include lower urinary tract conditions,  overactive bladder and urge incontinence,  Voiding postponement,  underactive bladder, and  Dysfunctional voiding, Abnormal bowel patterns  constipation and  encopresis.
  • 59. BBD IN INFANTS BBD in >2-year-old children is characterized by a combination of the following symptoms:  urgency,  urge incontinence,  frequency,  Infrequent voiding, and  constipation. Nearly half of infants with dilating VUR have dysfunctional voiding,  including enlarged bladder capacity,  overactive bladder, and  incomplete bladder emptying;  bowel dysfunction has not been systematically assessed in this patient population.
  • 60.
  • 61.
  • 62. PHARMACOLOGIC THERAPY ANTICHOLINERGIC THERAPY Oxybutynin - 2.5–5 mg tid approved for use in children Hyoscyamine- 0.125-0.25 mg qid sunlingual Tolterodine- 1-2 mg bd Tropsium 10- 25 mg bd Dairfenacin Solifenacin propiverine ALPHA BLOCKER THERAPY For pelvic floor overactivity and significant post void residual urine volumes Doxazosin 0.5 mg- decrease in incontinence
  • 63. SURGICAL MANAGEMENT PRINCIPLES OF SURGICAL MANAGEMENT 1. Exclude secondary reflux 2. Adequate ureteral mobilization without tension and protection of the ureteral blood supply 3. A generous submucosal tunnel should be fashioned 4. Attention should be directed to prevent angulation and twisting bladder tissues must be handled gently 5. Attention to muscular backing of ureter to achieve effective anti refux mechanism. 6. Creation of submucosal tunnel that satisfy 5:1 ratio of length and width recommended by Paquin.
  • 64. INDICATIONS ABSOLUTE INDICATIONS : Breakthrough urinary tract infections Failure of medical management - patient noncompliance - persistance of reflux with prolonged medical management. - progressive deterioration in renal function. Ureteral obstruction assoc with VUR Refluxing ureter opening into bladder diverticulum Cystoscopic observation of golf hole orifice
  • 65. RELATIVE INDICATIONS : Presence of massive reflux – gr IV & V Reflux associated with paraureteral diverticulum In girls whose reflux persists after they have reached the full somatic growth potential at puberty. Parental preference
  • 66. CLASSIFICATION According to approach : Intravesical Extravesical Combined According to the position of the sub mucosal tunnel in relation to the original hiatus : Suprahiatal Infrahiatal
  • 67.
  • 68. FOLLOW UP Discharged on uro-prophylaxis Monitoring of pt’s - BP - renal function - urine analysis Follow up USG and urine c/s after 6-12 weeks. VCUG after 3 mnths Discontinuation of uroprophylaxis on resolution of reflux DMSA after 1 yr (not mandatory)
  • 69. COMPLICATIONS Persistent Reflux. Early reflux following ureteroneocystostomy is usually not a significant clinical problem and commonly resolves by 1 year on repeat cystography. Contralateral reflux Seen in 5-11% cases There was no difference noted among the various surgical techniques, but there was a significant trend toward development of contralateral reflux with the higher grades of ipsilateral corrected reflux and correction of reflux in duplex systems.
  • 70. Prophylactic bilateral reimplantation for unilateral reflux, to avoid Contralateral reflux, is not warranted on the basis of the high spontaneous resolution rates. Obstruction Due to odema , clot ,twisting or kinking of ureter. Diagnosis made by USG showing severe HDUN. PCN or stenting has to be done. Redo surgery may be required
  • 71. ENDOSCOPIC MANAGEMENT Injection of a bio- compatible bulking agent beneath intravesical portion of ureter in sub-mucosal tunnel Elevates the intra-vesical ureter narrowing of lumen Prevents regurgitation of urine & allows antegrade flow
  • 72. ADVANTAGES OPD based treatment less morbidity, no mortality No surgical scar Success rate almost equivalent to open surgery forprimary reflux. DISADVANTAGES Cost Lower success rate compared to surgery for high grade reflux,upto 90%.
  • 73. ADVANTAGES OPD based treatment less morbidity, no mortality No surgical scar Success rate almost equivalent to open surgery for primary reflux. DISADVANTAGES Cost Lower success rate compared to surgery for high grade reflux,upto 90%.
  • 74. DEFLUX Dextranomer/Hyaluronic Copolymer (DX/HA) is formed of crosslinked dextranomer microspheres (80 to 250 μm in diameter) suspended in a carrier gel of stabilized sodium hyaluronate. DX/HA is biodegradable, the carrier gel is reabsorbed, and the dextranomer microspheres capsulated by fibroblast migration and collagen ingrowth. DX/HA loses about 23% of its volume beyond 3 months of follow- up The appeal of Deflux is that it is a natural product that is easily administered without a ratcheted syringe through a smaller-gauge needle. It is currently the preferred agent for endoscopic correction in most
  • 75. TEFLON PASTE Teflon paste is relatively inexpensive; it is viscous and requires a ratcheted syringe for injection. Less used now because of concerns regarding distant migration of the PTFE particles. Particle size 10-100μm. Malizia demonstrated in experimental studies that the particles can migrate to regional lymph nodes and to distantorgans including the lung and the brain